CDAZX
Price
$8.17
Change
-$0.05 (-0.61%)
Updated
Oct 7 closing price
Net Assets
298.23M
REMIX
Price
$14.41
Change
-$0.08 (-0.55%)
Updated
Oct 7 closing price
Net Assets
745.39M
Interact to see
Advertisement

CDAZX vs REMIX

Header iconCDAZX vs REMIX Comparison
Open Charts CDAZX vs REMIXBanner chart's image
Multi-Manager Directional Alt Strat Inst
Price$8.17
Change-$0.05 (-0.61%)
VolumeN/A
Net Assets298.23M
Standpoint Multi-Asset Investor
Price$14.41
Change-$0.08 (-0.55%)
VolumeN/A
Net Assets745.39M
CDAZX vs REMIX Comparison Chart in %
View a ticker or compare two or three
VS
CDAZX vs. REMIX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDAZX is a Buy and REMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 745M vs. CDAZX (298M). REMIX pays higher dividends than CDAZX: REMIX (5.52) vs CDAZX (3.36). CDAZX was incepted earlier than REMIX: CDAZX (9 years) vs REMIX (6 years). CDAZX (2.38) is less costly to investors than REMIX (1.64). CDAZX has a lower initial minimum investment than REMIX: CDAZX (100) vs REMIX (2500). CDAZX annual gain was more profitable for investors over the last year : 11.92 vs. REMIX (3.33). REMIX return over 5 years is better than : 54.32 vs. CDAZX (41.72).
CDAZXREMIXCDAZX / REMIX
Total Expense Ratio2.241.51148%
Annual Report Gross Expense Ratio2.381.64145%
Fund Existence9 years6 years-
Gain YTD11.5331.613715%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets298M745M40%
Annual Yield % from dividends3.365.5261%
Returns for 1 year11.923.33358%
Returns for 3 years25.9914.78176%
Returns for 5 years41.7254.3277%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SER5.400.21
+4.05%
Serina Therapeutics
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
HLLY2.95-0.03
-1.01%
Holley
NVCR14.16-0.34
-2.34%
NovoCure Limited
BIO296.52-12.65
-4.09%
Bio-Rad Laboratories IncClass A